Rebiotix: Patients, Clinical Trials and Drug Development
December 18, 2018
Hosted by Nancy C. Caralla
Join us with guests Ken Blount, Ph.D., Chief Scientific Officer and Paul Plumb, Head of Clinical Operations from Rebiotix. Ken and Paul will discuss the gut microbiome and the role it plays in overall health and Rebiotix’s goal to rehabilitate the gut microbiome by utilizing their unique Microbiota Restoration Therapy™ (MRT) Platform through its extensive clinical trial program. The science behind their products, product development and how patients are an important part of helping develop new drugs will also be discussed.
C. diff. Spores and More
Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
“C. diff. Spores and More” is an educational program providing you with up-to-date information pertaining to C. diff. and Healthcare-Associated infections. Raising awareness through education and advocacy saves lives worldwide. Topics are of C. difficile infection (CDI) prevention, treatments, and environmental safety products along with Healthcare-Associated Infection (HAI) awareness and more. Our guests are topic experts discussing Antibiotic Resistance, Research and Development, Clinical trials, Nutrition Counseling, Microbiome, Mental health, C. diff. survivors, and so much more. Please join us every Tuesday at 10 AM Pacific Time on the VoiceAmerica Health and Wellness Channel.
Nancy C. Caralla
Nancy C. Caralla, a three time C. diff. survivor, healthcare professional, and now dedicated to “Raising C. diff. Awareness” worldwide. Through the experiences is why we are so passionate raising C. diff. awareness. The C Diff Foundation was brought to fruition in November 2012 with a mission to educate and advocate for C. diff. infection prevention, treatment, and environmental safety worldwide. We now join the many successful hosts and programs on VoiceAmerica to deliver life-saving information through our program; “C. diff. Spores and More.”